Strategies for Rotation between Gabapentinoids in the Inpatient Setting.

J Pain Palliat Care Pharmacother

Madison N. Irwin, PharmD is with Department of Pharmacy, Michigan Medicine, Ann Arbor, Michigan, USA and College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA. Kyle Quirk, PharmD is with Department of Pharmacy, Michigan Medicine, Ann Arbor, Michigan, USA, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA and Department of Pharmacy, Ohio State University James Cancer Hospital, Columbus, Ohio, USA. Andrea Banner, BS is in College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA. Kevin Hosseini, PharmD Candidate is in College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA. Michael A. Smith, PharmD, BCPS is with Department of Pharmacy, Michigan Medicine, Ann Arbor, Michigan, USA and College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA.

Published: March 2021

Guidance and evidence to support best practices in rotating between gabapentinoids is lacking. This retrospective cohort study was performed to describe and evaluate strategies for rotation. Patients rotated while admitted from June 1st, 2014 to April 25th, 2020 at a large, academic medical center were included. The primary outcome was the proportion of rotations using a direct switch strategy compared to a cross-taper strategy. Secondary outcomes were successful rotation, defined as stable or improved pain scores pre- to post-rotation, dose ratios, and adverse effects. A total of 67 patients were included. Median age was 50 years (35 - 59) and 58% (38) were male. The majority used a direct switch strategy (87%). Ninety-five percent of patients using the direct switch strategy and 78% of patients using the cross-taper strategy were successful. There was no difference in strategies between those who were successful and those who were not. analysis of patients with normal renal function (eGFR ≥ 50 mL/min/1.73 m) found that those who were successful were more likely to have used a direct switch strategy ( = 0.048). There were no differences in adverse effects. These findings suggest that either strategy is reasonable for gabapentinoid rotation in the inpatient setting.

Download full-text PDF

Source
http://dx.doi.org/10.1080/15360288.2020.1852358DOI Listing

Publication Analysis

Top Keywords

direct switch
16
switch strategy
16
strategies rotation
8
inpatient setting
8
cross-taper strategy
8
adverse effects
8
strategy
7
patients
5
rotation gabapentinoids
4
gabapentinoids inpatient
4

Similar Publications

Background: Paliperidone is a second-generation antipsychotic and the main active metabolite of risperidone, formulated to provide consistent therapeutic effects through an extended-release system, designed to provide consistent therapeutic effects through an extended-release formulation. While commonly used in clinical practice, switching from risperidone to paliperidone, particularly during valproate therapy, can pose challenges due to potential pharmacokinetic interactions that may increase the risk of extrapyramidal symptoms (EPS). Despite clinical observations suggesting these interactions, case reports documenting such adverse effects are scarce.

View Article and Find Full Text PDF

Educational researchers have a long-lasting interest in the strategies examinees employ when responding to items in an assessment. Mixture item response theory (IRT) modeling is a popular class of approaches to studying examinees' item-response strategies. In the present study, we introduce a response time (RT)-based mixture IRT model for flexible modeling of examinee-and-item-specific item-response strategies.

View Article and Find Full Text PDF

Introduction: In the advanced stages of Parkinson's disease (PD), when standard drug adjustments fail to sufficiently improve patients' quality of life, device-aided therapies (DATs) such as deep brain stimulation (DBS), continuous subcutaneous apomorphine infusion (CSAI), levodopa-carbidopa intestinal gel infusion (LCIG), levodopa-carbidopa-entacapone intestinal gel infusion, or continuous subcutaneous foslevodoa-foscarbidopa infusion are beneficial in the long run. However, sometimes patients need to switch or combine DATs due to either adverse events or loss of efficacy.

Aim Of Study: The aim of this article was to summarise the existing data on the long-term efficacy and adverse events of DATs, and to review the data on the rationale and efficacy for switching or combining DATs in advanced PD.

View Article and Find Full Text PDF

Background: Availability of amyloid modifying therapies will dramatically increase the need for disclosure of Alzheimer's disease (AD) related genetic and/or biomarker test results. The 21st Century Cares Act requires the immediate return of most medical test results, including AD biomarkers. A shortage of genetic counselors and dementia specialists already exists, thus driving the need for scalable methods to responsibly communicate test results.

View Article and Find Full Text PDF

Twisting 2D van der Waals magnets allows the formation and control of different spin-textures, as skyrmions or magnetic domains. Beyond the rotation angle, different spin reversal processes can be engineered by increasing the number of magnetic layers forming the twisted van der Waals heterostructure. Here, pristine monolayers and bilayers of the A-type antiferromagnet CrSBr are considered as building blocks.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!